|Pernix Therapeutics Inc. to Report First Quarter 2015 Financial Results|
MORRISTOWN, NJ – (BUSINESS WIRE) – April 17, 2015 – Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced today that it will release its first quarter 2015 financial results on Friday, May 1, 2015, before the market opens.
Doug Drysdale, Chairman and Chief Executive Officer, and Sanjay Patel, Chief Financial Officer, will host a conference call to discuss the results as follows:
Date: Friday, May 1, 2015
Time: 8:30 A.M. EDT
Toll free: (U.S.) 877-312-8783
The presentation will be webcast and available on the Investors section of the Company’s website at http://www.pernixtx.com/investors/webcasts-presentations/. A replay of the webcast will be available for 30 days after the date of the presentation.
About Pernix Therapeutics
Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and psychiatry, and has an interest in expanding into additional specialty segments.
To learn more about Pernix Therapeutics, visit www.pernixtx.com.